Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor and Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT03322384
What this trial is testing

UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
University of California, Davis 20
Testing effectiveness (Phase 2)Looking for participantsNCT05384626
What this trial is testing

Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 840
Early research (Phase 1)Not Yet RecruitingNCT07583771
What this trial is testing

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

Who this might be right for
Pancreatic AdenocarcinomaNon Small Cell Lung CancerAdvanced Solid Tumors+2 more
Chipscreen Biosciences, Ltd. 186
Early research (Phase 1)Study completedNCT03654716
What this trial is testing

Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

Who this might be right for
LeukemiaBrain TumorSolid Tumor+1 more
Dana-Farber Cancer Institute 21
Early research (Phase 1)Study completedNCT01121133
What this trial is testing

Assess the Effect of Rifampin on the Metabolism of Navitoclax

Who this might be right for
Lymphoma, Including Chronic Lymphocytic LeukemiaSolid Tumors
AbbVie 12
Early research (Phase 1)WithdrawnNCT03359733
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

Who this might be right for
Lymphoma, MalignantAdvanced Solid Neoplasms
Calithera Biosciences, Inc
Early research (Phase 1)Active Not RecruitingNCT05460767
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid Tumors or Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 504
Early research (Phase 1)Study completedNCT02000934
What this trial is testing

TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies

Who this might be right for
Advanced Solid Tumor and Lymphoma Malignancies
Calithera Biosciences, Inc 143
Early research (Phase 1)Ended earlyNCT04986865
What this trial is testing

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorMature B-cell Non-Hodgkin Lymphoma
Antengene Biologics Limited 31
Early research (Phase 1)Study completedNCT02392611
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Solid Tumors and Lymphomas
Gilead Sciences 33
Not applicableWithdrawnNCT05169151
What this trial is testing

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

Who this might be right for
Central Nervous System NeoplasmHodgkin LymphomaMalignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT00578942
What this trial is testing

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 48
Early research (Phase 1)Study completedNCT01279603
What this trial is testing

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

Who this might be right for
Solid Tumors
Genus Oncology, LLC 23
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Testing effectiveness (Phase 2)UnknownNCT04458389
What this trial is testing

TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Who this might be right for
Locally Advanced /Metastatic Solid TumorsRelapsed or Refractory Lymphomas
Tayu Huaxia Biotech Medical Group Co., Ltd. 268
Not applicableAvailableNCT05974410
What this trial is testing

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc
Early research (Phase 1)Active Not RecruitingNCT01697930
What this trial is testing

A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)

Who this might be right for
Solid MalignancyLymphoma
Memorial Sloan Kettering Cancer Center 67
Next Page